IL23R and cancer: This duality is reflected in genetic and preclinical data: IL-23R polymorphisms may confer varying cancer risks (37), and IL-23 deficiency in mice increases susceptibility to certain tumors, likely by impairing immune surveillance and cellular homeostasis (39, 40).